Healthcare · Diagnostics Research · NYSE
| Market cap | $41.23B |
|---|---|
| Trailing P/E | 25.1 |
| FCF yield | 2.8% |
| Revenue growth (YoY) | +6.7% |
| EPS growth (YoY) | +5.5% |
| FCF/share growth (YoY) | -14.3% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Agilent Technologies, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Lisa McClain | House | Sell | $1,001 - $15,000 | Aug 13, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | May 15, 2025 |
| Jefferson Shreve | House | Buy | $15,001 - $50,000 | Apr 25, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | Mar 28, 2025 |
| Peter Welch | House | Sell | $1,001 - $15,000 | Nov 18, 2021 |
| Peter Meijer | House | Sell | $1,001 - $15,000 | Feb 19, 2021 |
| Peter Welch | House | Buy | $1,001 - $15,000 | May 28, 2019 |
| Lamar Smith | House | Buy | $1,001 - $15,000 | Jun 8, 2018 |
| James M Inhofe | Senate | Sell | $50,001 - $100,000 | — |
| James M Inhofe | Senate | Buy | $15,001 - $50,000 | — |
| Sheldon Whitehouse | Senate | Sell | $1,001 - $15,000 | — |
| Sheldon Whitehouse | Senate | Buy | $1,001 - $15,000 | — |